Ex-FDA Head To Testify In GSK Flonase Antitrust Row

Law360, Philadelphia (November 1, 2012, 4:57 PM EDT) -- A Pennsylvania federal judge struck a blow to GlaxoSmithKline PLC on Thursday, ruling that plaintiffs in a class action accusing it of illegally blocking development of a generic Flonase could tap former U.S. Food and Drug Administration chief David Kessler as an expert witness.

U.S. District Judge Anita Brody rejected GSK’s motion to exclude Kessler’s testimony, ruling that his experience with the agency made qualified him to render an opinion on whether the pharmaceutical company, as the plaintiffs allege, filed baseless petitions with the FDA in...
To view the full article, register now.